chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Skin warm
Clinical narrative: Initial information was received on 12 November 2008 from a health care professional. A "40-50 year old female patient received a left deltoid intramuscular injection of FLUZONE (lot number U2762AA) on 11 November 2008. Shortly after receiving the vaccination, on 11 November 2008, the patient developed right arm warmth and redness from her shoulder to her elbow. She was treated with Prednisone and BENADRYL. The patient's recovery status was not reported. Follow-up information was received 01 December 2008 from a consumer, who is also the patient. The patient had no concurrent illness at the time of vaccination and had recovered from the event. List of Documents held by Sender: None.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Hyperventilation, Lacrimation increased, Nasal congestion, Ocular hyperaemia
Clinical narrative: This non-serious event was reported by a health care professional on 13 January 2009.  This patient is one of a cluster of 20 patients; the other 19 are captured in case numbers 2008-03509 (corrected from 2008-03059), 2009-00153 to -00155, and -00157 to -00171.  A female patient received an injection of FLUZONE SV 2008-2009 (lot number U2762A; date and administration details not reported).  On 14 October 2008, she developed ocular respiratory syndrome, complaining of red eyes, nasal congestion, chest tightness, and sore throat.  Outcome was not reported.  Follow-up information was received from the health professional on 13 February 2009.  The patient received the vaccination intramuscularly in the deltoid on 14 October 2008.  Three hours post-vaccination, her eyes became bright red with tearing, nasal congestion, sore throat, and chest tightness.  The event was treated with BENADRYL, MOTRIN, and an ALBUTEROL inhaler.  The red eyes lasted for 24 hours, and the heavy breathing and congestion resolved after four days.  The event recovered.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Oculorespiratory syndrome, Oropharyngeal pain
Clinical narrative: This non-serious event was reported by a health care professional on 13 January 2009.  This patient is one of a cluster of 20 patients; the other 19 are captured in case numbers 2008-03509 (corrected from 2008-03059), 2009-00153 to -00155, and -00157 to -00171.  A female patient received an injection of FLUZONE SV 2008-2009 (lot number U2762A; date and administration details not reported).  On 14 October 2008, she developed ocular respiratory syndrome, complaining of red eyes, nasal congestion, chest tightness, and sore throat.  Outcome was not reported.  Follow-up information was received from the health professional on 13 February 2009.  The patient received the vaccination intramuscularly in the deltoid on 14 October 2008.  Three hours post-vaccination, her eyes became bright red with tearing, nasal congestion, sore throat, and chest tightness.  The event was treated with BENADRYL, MOTRIN, and an ALBUTEROL inhaler.  The red eyes lasted for 24 hours, and the heavy breathing and congestion resolved after four days.  The event recovered.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Chills, Hyperhidrosis, Pain
Clinical narrative: This non-serious event was reported by a health care professional on 13 January 2009. This patient is one of a cluster of 20 patient; the other 19 are captured in case numbers 2008-03509, 2009-00153 to 00160, and 2009-00162 to -00171. A female patient received an injection of FLUZONE SV 2008-2009 (lot number U2762AA; date administration details not reported). On 15 October 2008, the nurse was notified that the patient had complained of aches, chills, sweats, and called off; however the start date of the events were not provided. Outcome was not reported. Follow-up information was received from the health care professional on 13 February 2009. The patient was 30-years-old at the time of the event. On 15 October 2008, the patient received an intramuscular deltoid injection of FLUZONE. Symptoms began approximately 72 hours after vaccination, and she missed one day of work. The patient could not remember if she had taken any treatment medications. Symptoms lasted three days, and subsequently recovered. Documents held by sender: None
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Crying, Injection site pain, Pain, Pain in extremity
Clinical narrative: This non-serious event was reported by a health care professional on 13 January 2009.  This patient is one of a cluster of 20 patients; the other 19 patients are captured in case numbers 2008-03509, 2009-00153 to 2009-00162, and 2009-00164 to 2009-00171.  A patient (demographics not provided) received an injection of FLUZONE SV 2008-2009 (lot number U2762AA); however, the date, route and site of administration were not provided.  On 23 October 2008, the reporter recorded that at an unspecified amount of time after receiving the vaccination, the patient developed throbbing pain, crying and sore arm.  Part of the description of the event was illegible.  The throbbing stopped on 15 October 2008.  It was not reported whether the patient required medical intervention or received treatment.  Outcome was not reported for the other events.  Follow-up information was received from the health care professional on 13 February 2009.  The patient was 48-years-old at the time of the event.  On 23 October 2008, she received an intramuscular injection of FLUZONE in her deltoid.  Later that day she experienced severe throbbing pain in the arm, from the scapula down into the thumb.  This lasted seven hours; the events were considered to be completely resolved within 24 hours.  Treatment medications included TYLENOL and Ibuprofen.  Documents held by sender:  None
Age: 48.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Fatigue, Pain, Palpitations, Pyrexia
Clinical narrative: Initial report received on 13 November 2008 from a health care professional. A 48-year-old male patient, who had no concurrent illnesses or pre-existing conditions, and who had no known allergies, had received a 0.5 mL intramuscular injection of Fluzone SV 2008-200 (lot number U2741AA) on 01 November 2008. Approximately 24 hours later, on 02 November 2008, the patient experienced a temperature of 102.0 degrees Fahrenheit, aches, weakness, fatigue and heart palpitations. The heart palpitations lasted five days. The reporter did not know any other details, or if the patient was evaluated by a physician. It was "unknown" if any diagnostic tests or laboratory data were performed or collected. At the time of this report, the patient's recovery status was "unknown." Follow-up information received 04 February 2009 from a health care professional who reviewed the case, and had no additional information to provide at this time. Documents held by sender: None
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dysphonia, Eye swelling
Clinical narrative: Initial information was received on 13 November 2008 from a health care professional. A 32 year old female with a history of gastroesophageal reflux disease (GERD), urticaria, breast pain and no unknown allergies received an injection of Fluzone (lot number U2763AA) on 17 October 2008. The patient's last dose of Fluzone was in 1997. On 20 October 2008 the patient experienced eye swelling, cough and hoarseness. She was treated with Atarax and the symptoms had completely resolved. List of Documents held by Sender: None.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Activities of daily living impaired, Asthenia, Chills, Ocular hyperaemia, Pharyngeal oedema
Clinical narrative: This non-serious event was reported by a health care professional in a country on 13 January 2009. This patient is one of a cluster of 20 patients; the other 19 patients are captured in case numbers 2008-03509, 2009-00153 to 2009-00163, and 2009-00165 to 2009-00171. A male patient, had received an injection of FLUZONE SV 2008-2009 (lot number U2762AA); however, the date, route and site of administration were not provided. On 29 October 2008 the reporter recorded that approximately three hours post-vaccination, the patient's throat felt like it was swelling; his eyes were red, he had a fever and chills and he was experiencing weakness. The patient missed on day of school. It was not reported whether the patient required medical evaluation, or if he received any treatment. Outcome was not reported. Follow-up information was received from the health care professional on 13 February 2009. The patient was 45-years-old at the time of the event. On 29 October 2008, he received an intramuscular deltoid injection of FLUZONE. He did not require any treatment, and all events recovered with 24 hours. Documents held by sender: None.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia
Clinical narrative: This non-serious event was reported by a health care professional in a country on 13 January 2009. This patient is one of a cluster of 20 patients; the other 19 patients are captured in case numbers 2008-03509, 2009-00153 to 2009-00163, and 2009-00165 to 2009-00171. A male patient, had received an injection of FLUZONE SV 2008-2009 (lot number U2762AA); however, the date, route and site of administration were not provided. On 29 October 2008 the reporter recorded that approximately three hours post-vaccination, the patient's throat felt like it was swelling; his eyes were red, he had a fever and chills and he was experiencing weakness. The patient missed on day of school. It was not reported whether the patient required medical evaluation, or if he received any treatment. Outcome was not reported. Follow-up information was received from the health care professional on 13 February 2009. The patient was 45-years-old at the time of the event. On 29 October 2008, he received an intramuscular deltoid injection of FLUZONE. He did not require any treatment, and all events recovered with 24 hours. Documents held by sender: None.
Age: 1.7
Sex: F
Vaccine: FLU3, HEPA
Symptoms: Ataxia, Clumsiness, Coordination abnormal
Clinical narrative: Ataxia, clumsiness, lack of coordination, Initial report received on 17 November 2008 from a patient's parent, who is a physician. A 23 month old female patient experienced mild ataxia 16 days after she had received left thigh intramuscular injection of FLUZONE SV 2008-2009 (lot number U2808AA) and a dose of Hepatitis A vaccine (trade name, manufacturer, lot number, route/site of administration not reported). The patient experienced clumsy behavior and was not able to grasp things when she reached out for hem. There were no other symptoms. At this time of the report, the symptoms persisted. Patient outcome unknown.  Follow-up information was received  on 19 February 2009 from patient's parent. The patient received HAVRIX, hepatitis A vaccine (manufacturer GSK, lot number AHAVB289AA) intramuscularly. The patient did not require treatment, laboratory or diagnostic tests. The patient's symptoms resolved within two and three days from the date of onset.
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles
Clinical narrative: A cluster of 2 female patients who received FLUZONE (lot number U2853AB) and Pneumococcal vaccine, and developed injection site pain, redness, and swelling at an unknown time after vaccination. Initial report received on 20 November 2008 from a healthcare professional. A female patient, whose medical history and concomitant medications were unknown, received on 20 October 2008 an intramuscular injection of FLUZONE (lot number U2853AB) and and intramuscular injection of a Pneumococcal vaccine (Merck, lot number 0555EU). Both vaccines were administered in the same arm at the same site. The patient had no illness at the time of vaccination. After an unknown amount of time, the patient experienced pain, redness, swelling and blister formation at and around the injection site. The patient was evaluated by a physician and received treatment with oral antibiotics. The patient's outcome was not reported. Case 2008-03697 with the same reporter, same vaccines and same lot numbers was created for the other patient.
Sex: F
Vaccine: FLU3
Symptoms: Abdominal pain, Back pain, Pain in extremity
Clinical narrative: A female whose age and medical history were not reported, received an injection of Fluzone (lot number, dosage, route and site not reported) on 21 November 2008. Two hours after vaccination, the patient was brought to the reporter's office with leg, back and abdominal pain. There was no vomiting or diarrhea. Corrective treatment was Benadryl. The outcome was not reported. The reporter would not give further information.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Nodule, Oedema peripheral
Clinical narrative: Initial report received 17 February 2009 from a health care professional. A 27-year-old female patient had received an injection of FLUZONE (lot number, route and site of administration not reported) on 16 February 2009 and one day later, she developed a swollen arm, a golf ball size know and a "reddened fleshy part of her arm". The patient's recovery status was unknown. No additional information was provided at the time of the report.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chills, Decreased appetite, Myalgia, Pyrexia
Clinical narrative: Chest tightness, wheezing, fever, chills, generalized muscle aches, appetite absent. Initial report received on 21 November from a health professional. A 49 year old female, whose medical history and concomitant medications were unknown received a right deltoid intramuscular injection of FLUZONE (lot number U2760AA) on 20 November 2008. The patient had no illness at the time of vaccination. Thirty minutes after vaccination, the patient felt chest tightness and wheezing. Within another hour, the patient experienced fever, achiness, and chills. The patient also had no appetite. Corrective treatment was not reported. The patient had recovered on 21 November 2008. Follow up information was received on 29 December 2008 from a healthcare professional. The reported indicated that there was no new information to report. Follow-up information received 23 January 2009 from a healthcare professional who reviewed the case had no new relevant medically significant information to provide at this time. Follow-up information received on 09 March 2009 from a healthcare professional. The patient had no medical history and no concomitant medications. It was unknown if she had received Fluzone in the past, but she had previously received flu shots. The symptoms were reported to have lasted seven hours. The patient was not evaluated by a health professional.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: Chest tightness, wheezing, fever, chills, generalized muscle aches, appetite absent. Initial report received on 21 November from a health professional. A 49 year old female, whose medical history and concomitant medications were unknown received a right deltoid intramuscular injection of FLUZONE (lot number U2760AA) on 20 November 2008. The patient had no illness at the time of vaccination. Thirty minutes after vaccination, the patient felt chest tightness and wheezing. Within another hour, the patient experienced fever, achiness, and chills. The patient also had no appetite. Corrective treatment was not reported. The patient had recovered on 21 November 2008. Follow up information was received on 29 December 2008 from a healthcare professional. The reported indicated that there was no new information to report. Follow-up information received 23 January 2009 from a healthcare professional who reviewed the case had no new relevant medically significant information to provide at this time. Follow-up information received on 09 March 2009 from a healthcare professional. The patient had no medical history and no concomitant medications. It was unknown if she had received Fluzone in the past, but she had previously received flu shots. The symptoms were reported to have lasted seven hours. The patient was not evaluated by a health professional.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chest discomfort, Cough, Disorientation, Eye discharge
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 328982) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV 2008-2009 (lot number 6714940) intramuscularly on 15 October 2008 at 1:00 PM. The patient began feeling a little disoriented and her arm ached. At 5:00 PM she developed a heavy, wheezing feeling in her chest with a cough. Her body was aching, her eyes became red and irritated. At approximately 3:00 AM she woke up and her eyes were swollen and almost matted shut. She went to the doctor's at 10:30 AM the following day. The doctor did not think the patient's symptoms were related to FLUZONE. She thought the patient had a virus. The patient was instructed to take TYLENOL cold medicine, BENADRYL, and rest. The patient continued to complain of aching and a very weak feeling, but her low grade fever resolved. The patient's recovery status was not reported. No further information was reported. List of Documents held by Sender: none.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Eye irritation, Eye swelling, Feeling abnormal, Ocular hyperaemia, Pain
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 328982) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV 2008-2009 (lot number 6714940) intramuscularly on 15 October 2008 at 1:00 PM. The patient began feeling a little disoriented and her arm ached. At 5:00 PM she developed a heavy, wheezing feeling in her chest with a cough. Her body was aching, her eyes became red and irritated. At approximately 3:00 AM she woke up and her eyes were swollen and almost matted shut. She went to the doctor's at 10:30 AM the following day. The doctor did not think the patient's symptoms were related to FLUZONE. She thought the patient had a virus. The patient was instructed to take TYLENOL cold medicine, BENADRYL, and rest. The patient continued to complain of aching and a very weak feeling, but her low grade fever resolved. The patient's recovery status was not reported. No further information was reported. List of Documents held by Sender: none.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Pyrexia, Wheezing
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 328982) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV 2008-2009 (lot number 6714940) intramuscularly on 15 October 2008 at 1:00 PM. The patient began feeling a little disoriented and her arm ached. At 5:00 PM she developed a heavy, wheezing feeling in her chest with a cough. Her body was aching, her eyes became red and irritated. At approximately 3:00 AM she woke up and her eyes were swollen and almost matted shut. She went to the doctor's at 10:30 AM the following day. The doctor did not think the patient's symptoms were related to FLUZONE. She thought the patient had a virus. The patient was instructed to take TYLENOL cold medicine, BENADRYL, and rest. The patient continued to complain of aching and a very weak feeling, but her low grade fever resolved. The patient's recovery status was not reported. No further information was reported. List of Documents held by Sender: none.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chest pain, Cough, Dyspnoea, Fatigue
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 329956).  A 57-year-old female patient had received a first dose intramuscular injection of FLUZONE (site not reported), lot number U2750AA on 21 October 2008 at 11:40 hours, she began coughing and the whites of her eyes turned red.  At 18:40, her eyes were very red and she had difficulty breathing and her skin was in pain.  By 22:30 hours, her body was in a lot of pain and pain was described as an ice pick stabbing her mid section all over.  At 03:20 hours, pain was described as an ice pick stabbing her heart, with heart reacting, chest tightening, felt very cold, face swollen, itching on the top of her head, a terrible headache, and sinus pressure.  By 06:20 hours, her symptoms began to subside.  At 13:00 hours, her headache continued, but she was able to breath better and felt recovery coming.  By 18:00 hours, she was able to consume food.  On 23 October and 24 October 2008, she was able to attend to business but felt tired and like her organs and muscles had been through a spin cycle.  The patient recovered from the event.  Documents help by sender:  None
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling abnormal, Feeling cold, Headache, Ocular hyperaemia, Pain
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 329956).  A 57-year-old female patient had received a first dose intramuscular injection of FLUZONE (site not reported), lot number U2750AA on 21 October 2008 at 11:40 hours, she began coughing and the whites of her eyes turned red.  At 18:40, her eyes were very red and she had difficulty breathing and her skin was in pain.  By 22:30 hours, her body was in a lot of pain and pain was described as an ice pick stabbing her mid section all over.  At 03:20 hours, pain was described as an ice pick stabbing her heart, with heart reacting, chest tightening, felt very cold, face swollen, itching on the top of her head, a terrible headache, and sinus pressure.  By 06:20 hours, her symptoms began to subside.  At 13:00 hours, her headache continued, but she was able to breath better and felt recovery coming.  By 18:00 hours, she was able to consume food.  On 23 October and 24 October 2008, she was able to attend to business but felt tired and like her organs and muscles had been through a spin cycle.  The patient recovered from the event.  Documents help by sender:  None
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Pain of skin, Pruritus, Sinus headache, Swelling face
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference number 329956).  A 57-year-old female patient had received a first dose intramuscular injection of FLUZONE (site not reported), lot number U2750AA on 21 October 2008 at 11:40 hours, she began coughing and the whites of her eyes turned red.  At 18:40, her eyes were very red and she had difficulty breathing and her skin was in pain.  By 22:30 hours, her body was in a lot of pain and pain was described as an ice pick stabbing her mid section all over.  At 03:20 hours, pain was described as an ice pick stabbing her heart, with heart reacting, chest tightening, felt very cold, face swollen, itching on the top of her head, a terrible headache, and sinus pressure.  By 06:20 hours, her symptoms began to subside.  At 13:00 hours, her headache continued, but she was able to breath better and felt recovery coming.  By 18:00 hours, she was able to consume food.  On 23 October and 24 October 2008, she was able to attend to business but felt tired and like her organs and muscles had been through a spin cycle.  The patient recovered from the event.  Documents help by sender:  None
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Eye discharge, Eye pruritus, Fatigue, Headache
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 329987) via a search of the QSCAN database. A 39 year old female received FLUZONE SV 2008-2009 (lot number U2740AA) intramuscular on 15 October 2008. One hour post vaccination the patient developed heaviness in the arm which was injected, redness, swelling, discharge, and itching in her eyes, fever, fatigue and head pressure. The patient was reported as recovered. No further information was received. List of Documents held by Sender: none.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Sensation of heaviness, Swelling
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 329987) via a search of the QSCAN database. A 39 year old female received FLUZONE SV 2008-2009 (lot number U2740AA) intramuscular on 15 October 2008. One hour post vaccination the patient developed heaviness in the arm which was injected, redness, swelling, discharge, and itching in her eyes, fever, fatigue and head pressure. The patient was reported as recovered. No further information was received. List of Documents held by Sender: none.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Chills, Conjunctivitis, Headache, Myalgia
Clinical narrative: This case was extracted from the VAERS database via a search of QSCAN on 24 February 2009 (reference number 331012). A 45-year-old female patient received an intramuscular injection of FLUZONE (lot number 2755AA) on 22 October 2008. Approximately two hours after vaccination, she experienced fever, chills, seizing chest pain, sore throat, headache, conjunctivitis, muscle aches, and nausea. She presented to the clinic for evaluation; treatment was not reported. All events except conjunctivitis resolved within 12 hours.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: This case was extracted from the VAERS database via a search of QSCAN on 24 February 2009 (reference number 331012). A 45-year-old female patient received an intramuscular injection of FLUZONE (lot number 2755AA) on 22 October 2008. Approximately two hours after vaccination, she experienced fever, chills, seizing chest pain, sore throat, headache, conjunctivitis, muscle aches, and nausea. She presented to the clinic for evaluation; treatment was not reported. All events except conjunctivitis resolved within 12 hours.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Condition aggravated, Cough, Eye irritation, Headache
Clinical narrative: This non serious case was received on 24 February 2009 via a search of the VAERS database (reference number 330101). A 52 year old male received FLUZONE SV 2008-2009 (lot number U2757AA) on 16 October 2008. At 3:30 pm post vaccination, the patient had a feeling of a lump in their throat. At 6:30 pm the patient was not feeling well and the lump in their throat caused coughing. The patient had an increase in nausea in the evening and his eyes were burning and had turned red. At 10 pm the patient had an increased in nausea in the evening and his eyes turned blood red. That night he developed a fever, malaise, headache, and weakness. His symptoms continued through 17 October 2008. He felt better on 19 October 2008 and was reported as recovered. No further information was reported. List of Documents held by sender: None.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Malaise, Nausea, Ocular hyperaemia, Pyrexia, Sensation of foreign body
Clinical narrative: This non serious case was received on 24 February 2009 via a search of the VAERS database (reference number 330101). A 52 year old male received FLUZONE SV 2008-2009 (lot number U2757AA) on 16 October 2008. At 3:30 pm post vaccination, the patient had a feeling of a lump in their throat. At 6:30 pm the patient was not feeling well and the lump in their throat caused coughing. The patient had an increase in nausea in the evening and his eyes were burning and had turned red. At 10 pm the patient had an increased in nausea in the evening and his eyes turned blood red. That night he developed a fever, malaise, headache, and weakness. His symptoms continued through 17 October 2008. He felt better on 19 October 2008 and was reported as recovered. No further information was reported. List of Documents held by sender: None.
Sex: M
Vaccine: FLU3
Symptoms: Dysgeusia, Myalgia
Clinical narrative: A male patient (age not reported) complained of "feeling off", muscle aches and a "weird taste" in his mouth since he received FLUZONE SV 2008-2009 (lot number unknown, route/site of administration not reported) a few weeks ago. The patient declined to provide any additional information until he follows up with his physician. At the time of the report, the patient had not recovered. Documents held by sender: None.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Inflammation, Injection site erythema, Injection site swelling, Neck pain
Clinical narrative: Blurred vision, scleral discoloration, inflammation localized, neck pain, generalized aching, pain in arm, pain in hip. Initial consumer report received on 14 November 2008 from a patient. A 71 year female received on 07 November 2008 FLUZONE (lot # not reported), intramuscular into the left deltoid. By the evening of the day of vaccination she developed swelling the size of an egg at the left deltoid area that was red. The back of the neck hurt and she experienced severe generalized body aches. In the morning (08 November 2008), she had blurred vision and her scleras were red and yellowed. She self treated herself with metal detoxification. By 13 November 2008 she was feeling better, but still had arm and hip pain. The patient had no illness at vaccination time, no prior adverse event to vaccination and no relevant medical conditions.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Pain, Pain in extremity, Scleral discolouration, Vision blurred
Clinical narrative: Blurred vision, scleral discoloration, inflammation localized, neck pain, generalized aching, pain in arm, pain in hip. Initial consumer report received on 14 November 2008 from a patient. A 71 year female received on 07 November 2008 FLUZONE (lot # not reported), intramuscular into the left deltoid. By the evening of the day of vaccination she developed swelling the size of an egg at the left deltoid area that was red. The back of the neck hurt and she experienced severe generalized body aches. In the morning (08 November 2008), she had blurred vision and her scleras were red and yellowed. She self treated herself with metal detoxification. By 13 November 2008 she was feeling better, but still had arm and hip pain. The patient had no illness at vaccination time, no prior adverse event to vaccination and no relevant medical conditions.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Dyskinesia, Tic
Clinical narrative: Initial information was received on 18 November 2008 from a consumer (corrected on 17 August 2009). A four year old female with a history of sinus infection received an injection of Fluzone SV (lot number not reported) in the end of October or the first week in November. The patient's mother stated that one to two days post vaccination the patient began to have ticks which included jerking movements in her arm, moving her arm back and forth as well as sounds coming out of her mouth. Both symptoms were uncontrollable per the patient's mother. She was seen by her physician, who suggested sending the child to a neurologist if the symptoms persisted. The patient had not recovered at the time of the report. List Documents held by Sender: None.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dyspnoea, Ocular hyperaemia
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 251873) via a search of the QSCAN database. A 30 year old female patient received FLUZONE SV 2005-2006 USP (lot number U1873) intramuscularly on 03 January 2006.  Approximately 3 to 4 hours post vaccination, the patient's eyes became red, otherwise her were asymptomatic. Later that evening she had tightness and difficulty breathing. The patient recovered.
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Skin discolouration
Clinical narrative: Skin discoloration. Pain in arm. Initial information was received on 08 January 2009 from a consumer in the United States. A cluster of one patient out of two vaccines received an intramuscular injection of Fluzone SV 2008-2009 (lot number not reported) on an unspecified date. A few days later the male patient's shoulder to elbow became red, "as if there were bleeding in the tissue". The area then turned blue, then black and took two to three weeks to clear up. The patient had an aching pain when his arm was abducted. The patient did not provide further details. 18 February 2009: A new case was created to add that the reported for this case is the same as for case 2008-03739. The sentence below was amended and case number 2008-03739 was added in addition to case 2009-00060. List of Documents held by Sender: None. The reporter of this case is same as for case numbers 2009-00060 and 2008-03739.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Bed rest, Chills, Eye discharge, Headache, Injection site pain
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 264411) via a search of the QScan database. A 47 year old female patient received Fluzone SV '2006-'2007 USP (lot number 2186AA) on 10 October 2006. That same day the patient experienced a fever of 101.8, moderate muscle ache over the entire body, headache, chills, red eyes with white discharge, racing heart beat, swelling of the face and fingers, injection site soreness and a sore throat. The patient's symptoms required her to be on bed rest. she took Ibuprofen which eased the symptoms. Most symptoms were gone by the following morning except for the injection site soreness. The patient reported as recovered.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Ocular hyperaemia, Oedema peripheral, Oropharyngeal pain, Palpitations
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 264411) via a search of the QScan database. A 47 year old female patient received Fluzone SV '2006-'2007 USP (lot number 2186AA) on 10 October 2006. That same day the patient experienced a fever of 101.8, moderate muscle ache over the entire body, headache, chills, red eyes with white discharge, racing heart beat, swelling of the face and fingers, injection site soreness and a sore throat. The patient's symptoms required her to be on bed rest. she took Ibuprofen which eased the symptoms. Most symptoms were gone by the following morning except for the injection site soreness. The patient reported as recovered.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Swelling face
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 264411) via a search of the QScan database. A 47 year old female patient received Fluzone SV '2006-'2007 USP (lot number 2186AA) on 10 October 2006. That same day the patient experienced a fever of 101.8, moderate muscle ache over the entire body, headache, chills, red eyes with white discharge, racing heart beat, swelling of the face and fingers, injection site soreness and a sore throat. The patient's symptoms required her to be on bed rest. she took Ibuprofen which eased the symptoms. Most symptoms were gone by the following morning except for the injection site soreness. The patient reported as recovered.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Eye discharge, Ocular hyperaemia, Oral discomfort, Oropharyngeal pain
Clinical narrative: Ocular hyperemia, eye discharge, stomatitis, wheezing, face red, pharyngolaryngeal pain, vomiting, pain. This non serious case was received on 11 march 2009 from VAERS (reference number 265980) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV 2006-2007 (lot number U2717AA, which is invalid) intramuscularly on 02 November 2006. Approximately two hours after receiving flu vaccine the in side of the patient's mouth began burning and stinging. Her throat hurt and felt "like something was in it". Her face became red, eyes became bloodshot with a mucousy discharge. She began wheezing, vomiting, and became achy. She went to the urgent care facility and was given an anti-histamine. The patient reported a similar reaction to a flu vaccine which happened the prior year (manufacturer not provided). The patient was reported as recovered.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Stomatitis, Vomiting, Wheezing
Clinical narrative: Ocular hyperemia, eye discharge, stomatitis, wheezing, face red, pharyngolaryngeal pain, vomiting, pain. This non serious case was received on 11 march 2009 from VAERS (reference number 265980) via a search of the QSCAN database. A 43 year old female patient received FLUZONE SV 2006-2007 (lot number U2717AA, which is invalid) intramuscularly on 02 November 2006. Approximately two hours after receiving flu vaccine the in side of the patient's mouth began burning and stinging. Her throat hurt and felt "like something was in it". Her face became red, eyes became bloodshot with a mucousy discharge. She began wheezing, vomiting, and became achy. She went to the urgent care facility and was given an anti-histamine. The patient reported a similar reaction to a flu vaccine which happened the prior year (manufacturer not provided). The patient was reported as recovered.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Cough, Lacrimation increased, Ocular hyperaemia
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 266605). A 37-year-old female patient had received an injection of FLUZONE SV 2006-2007 (route site of administration not reported), lot number U2189AA on 01 November 2006 and six hours later she developed red watery eyes, a dry cough and chills(without fever body aches). All symptoms resolved approximately nine hours later and the patient recovered. No additional information was provided.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Cough, Ear congestion, Eye irritation, Full blood count
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 267304) via a search of the QScan database. A 32 year old female received Fluzone SV '2006-'2007 USP (lot number U2257AA) on 23 October 2006, An hour and a half later the patient developed chest tightness a "tickly" cough, red and burning eyes, congested ears, egg white rash, CBC (complete blood count) was completed. The patient was reported as recovered and required an emergency room doctor's visit.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Rash
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 267304) via a search of the QScan database. A 32 year old female received Fluzone SV '2006-'2007 USP (lot number U2257AA) on 23 October 2006, An hour and a half later the patient developed chest tightness a "tickly" cough, red and burning eyes, congested ears, egg white rash, CBC (complete blood count) was completed. The patient was reported as recovered and required an emergency room doctor's visit.
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Fatigue, Gingival bleeding, Myalgia, Ocular hyperaemia
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 268748) via a search of the QScan database. A 16 year old male received Fluzone sv '2006-'2007 USP (lot number U2279A) intramuscularly on 02 December 2006. Approximately six hours later the patient developed muscle aches, extreme fatigue, bleeding gums, swelling of tissue under the tongue, barking cough, and redness in the eyes. After 24 hours the patient's symptoms resolved. List of Documents held by Sender: none.
Age: 61.0
Sex: M
Vaccine: FLU3
Symptoms: Swollen tongue
Clinical narrative: This non serious case was received on 11 March 2009 from VAERS (reference number 268748) via a search of the QScan database. A 16 year old male received Fluzone sv '2006-'2007 USP (lot number U2279A) intramuscularly on 02 December 2006. Approximately six hours later the patient developed muscle aches, extreme fatigue, bleeding gums, swelling of tissue under the tongue, barking cough, and redness in the eyes. After 24 hours the patient's symptoms resolved. List of Documents held by Sender: none.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Cough, Eye pain, Ocular hyperaemia, Somnolence
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 292440). A 61-year-old female patient had received a tenth dose intramuscular injection of FLUZONE SV 2007-2008, lot number U2467AA on 05 October 2007 and  eight hours after vaccination she became very sleepy. The patient slept 12 hours straight and awoke with a cough, wheezing, tightness of her chest, red painful eyes with blurry vision and reported as recovered (date of recovery not reported).
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Vision blurred, Wheezing
Clinical narrative: This non serious case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 292440). A 61-year-old female patient had received a tenth dose intramuscular injection of FLUZONE SV 2007-2008, lot number U2467AA on 05 October 2007 and  eight hours after vaccination she became very sleepy. The patient slept 12 hours straight and awoke with a cough, wheezing, tightness of her chest, red painful eyes with blurry vision and reported as recovered (date of recovery not reported).
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Injection site pain, Ocular hyperaemia, Oropharyngeal pain, Paraesthesia
Clinical narrative: This case was extracted from the VAERS database via QScan on 11 March 2009 (lot number 293359). A 33-year-old female patient received an intramuscular injection of FLUZONE SV2007-2008(reference U2498AA) on 11 October 2007. Following vaccination, she developed a sore throat, shortness of breath, wheezing, red blurry eyes, and low grade fever. She also experienced tingling and soreness at the injection site, which lasted approximately 20 minutes. The patient sought medical attention, and the events subsequently resolved.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Vision blurred, Wheezing
Clinical narrative: This case was extracted from the VAERS database via QScan on 11 March 2009 (lot number 293359). A 33-year-old female patient received an intramuscular injection of FLUZONE SV2007-2008(reference U2498AA) on 11 October 2007. Following vaccination, she developed a sore throat, shortness of breath, wheezing, red blurry eyes, and low grade fever. She also experienced tingling and soreness at the injection site, which lasted approximately 20 minutes. The patient sought medical attention, and the events subsequently resolved.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Influenza like illness, Ocular hyperaemia, Palpitations, Wheezing
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 293493). A 55-year-old female patient received an intramuscular injection of FLUZONE 2007-2008 (lot number U2488AA). Approximately five hours after vaccination, the patient presented to the emergency department with a dry cough and red eyes. It was noted that the patient may have been experiencing an allergic reaction, and she was prescribed hydrocodone cough syrup and TAMIFLU (which she did not fill). The patient later experienced wheezing, cough, flu symptoms, and a racing heart. The events subsequently recovered.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Asthenia, Chills, Cough, Eye irritation
Clinical narrative: This case was extracted from the VAERS database via QScan on 11 March 2009 (reference number 294149). A 68-year-old female patient received an intramuscular injection of Fluzone SV 2007-2008 (lot number U2510AA) on 18 October 2007. Approximately one and one half to two hours post-vaccination, the patient experienced burning eyes which watered and were sensitive to light. After another hour her throat felt right and she developed a cough. She then complained of feeling feverish with aching joints and a pounding head. Her body "felt like it was in a vice", and she had chills. She took a Benadryl and went to bed. That night she did not sleep well, and continued to have a fever. The following morning her eyes ere stuck closed, she had weakness, joint and muscle aching and a headache. She took Benadryl and visine for allergies, and the events continued throughout the day. The following day the symptoms were mild and by the third day post-vaccination all events had recovered.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Insomnia, Lacrimation increased, Photophobia, Pyrexia
Clinical narrative: This case was extracted from the VAERS database via QScan on 11 March 2009 (reference number 294149). A 68-year-old female patient received an intramuscular injection of Fluzone SV 2007-2008 (lot number U2510AA) on 18 October 2007. Approximately one and one half to two hours post-vaccination, the patient experienced burning eyes which watered and were sensitive to light. After another hour her throat felt right and she developed a cough. She then complained of feeling feverish with aching joints and a pounding head. Her body "felt like it was in a vice", and she had chills. She took a Benadryl and went to bed. That night she did not sleep well, and continued to have a fever. The following morning her eyes ere stuck closed, she had weakness, joint and muscle aching and a headache. She took Benadryl and visine for allergies, and the events continued throughout the day. The following day the symptoms were mild and by the third day post-vaccination all events had recovered.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Throat tightness
Clinical narrative: This case was extracted from the VAERS database via QScan on 11 March 2009 (reference number 294149). A 68-year-old female patient received an intramuscular injection of Fluzone SV 2007-2008 (lot number U2510AA) on 18 October 2007. Approximately one and one half to two hours post-vaccination, the patient experienced burning eyes which watered and were sensitive to light. After another hour her throat felt right and she developed a cough. She then complained of feeling feverish with aching joints and a pounding head. Her body "felt like it was in a vice", and she had chills. She took a Benadryl and went to bed. That night she did not sleep well, and continued to have a fever. The following morning her eyes ere stuck closed, she had weakness, joint and muscle aching and a headache. She took Benadryl and visine for allergies, and the events continued throughout the day. The following day the symptoms were mild and by the third day post-vaccination all events had recovered.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Eye discharge, Hypoaesthesia oral, Local swelling, Ocular hyperaemia
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 294643). A 57-year-old male patient received an intramuscular injection of FLUZONE 2007-2008 (lot number U2526AA) on 26 October 2007. Approximately four hours post-vaccination, the patient developed a mild cough with throat irritation. Five hours post-vaccination, his neck felt swollen and he experienced numbness below the corners of his mouth. He developed red eyes with yellow discharge, and generalized achy feeling in his legs. He took 50mg diphenhydramine, and had symptomatic relief. The following morning he had ongoing throat thickness, and he took 25mg of diphenenhydramine. Symptoms resolved.
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Oropharyngeal pain, Pain, Pharyngeal oedema
Clinical narrative: This case was extracted from the VAERS database via QSCAN on 11 March 2009 (reference number 294643). A 57-year-old male patient received an intramuscular injection of FLUZONE 2007-2008 (lot number U2526AA) on 26 October 2007. Approximately four hours post-vaccination, the patient developed a mild cough with throat irritation. Five hours post-vaccination, his neck felt swollen and he experienced numbness below the corners of his mouth. He developed red eyes with yellow discharge, and generalized achy feeling in his legs. He took 50mg diphenhydramine, and had symptomatic relief. The following morning he had ongoing throat thickness, and he took 25mg of diphenenhydramine. Symptoms resolved.